Supply for Colchicine
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Deadline | 5 Mar 2021 |
| Contract start | 8 Mar 2021 |
| Contract end | 12 Apr 2021 |
| Procedure | limited |
| SME suitable | No |
| OCID | ocds-b5fd17-e3730c98-caf1-4e82-92ad-0642e3a6122b |
Awards (6)
This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd | £611,567 | 8 Mar 2021 | active |
| Accord-UK Ltd | £222,480 | 8 Mar 2021 | active |
| HFA Healthcare Products Limited | £174,350 | 8 Mar 2021 | active |
| Morningside Pharmaceuticals Ltd | £154,500 | 8 Mar 2021 | active |
| Sigma Pharmaceuticals plc | £9,940 | 8 Mar 2021 | active |
| Vertical Pharma Resources Limited | £50,297 | 8 Mar 2021 | active |
description
The Department of Health and Social Care conducted a negotiated procedure without prior publication under the Public Contracts Regulations 2015 (as amended) for the supply of Colchicine 500mcg tablets. The contract period expires on 12 April 2021.
notice history
5 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 7 Apr 2021 | Award (award) | · | 5872e0c7-d763-4151-bf8c-f4d96d25071e-426774 |
| 7 Apr 2021 | Award (award) | · | 8c10de6e-108a-482f-9e3d-be706cd09343-426775 |
| 7 Apr 2021 | Award (award) | · | d0abd6bd-d14c-4177-a808-2292434b3560-426776 |
| 7 Apr 2021 | Award (award) | · | b4458689-dc57-466a-8daa-455343b1e7d0-426777 |
| 7 Apr 2021 | Award (award) | · | e925b73f-8919-4fcd-b05f-4d111dc4c7bc-426778 |
more from Department of Health and Social Care (DHSC)
- Hugh's Report-MH Impact of Life-threatening Child Illness on families 2026 · £216,540 · 26 Jun 2026
- D&B + API Interface · £542,011 · 25 Jun 2026
- NCMP IT System - Discovery Phase · £183,768 · 19 May 2026
- DHSC: CL Temporary Executive Support to the Permanent Secretary - JW · £17,702 · 19 May 2026
- DHSC: GO: 26/27 - WIST: DAC hosting on CSP · £168,000 · 2 Apr 2026
- RM1043.8-1-DEPARTMENT OF HEALTH AND SOCIAL CARE - Find Public Health Data · £1,251,360 · 2 Apr 2026
- DHSC:NHST: National GP Engagement on Health Data · £267,000 · 31 Mar 2026
- DHSC: CL FGO Contingent Labour SD Extension · £133,710 · 31 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.